Use of intra‐aortic balloon pump during coronary artery bypass graft surgery. Current questions and few answers

Escutia-Cuevas, Héctor Hugo

doi:10.1111/jocs.15436

Cited by 2 publications

(2 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Lack of consensus in the surgical community on the de nition of high-risk patients further complicates the issue. While our study used EuroSCORE II > 1.2%, others de ned high-risk patients using various clinical variables [14,23,24]. Notably, the generalizability of IABP effects from studies like SHOCK II to bypass surgery patients is questioned [18].…”

Section: Discussionmentioning

confidence: 99%

Pre-operative intra-aortic balloon pump insertion in coronary artery bypass grafting patients reduces in-hospital morbidity

Sazzad,

Luo,

Chang

et al. 2024

Preprint

View full text Add to dashboard Cite

Background: The aim of this study was to determine if pre-operative intra-aortic balloon pump (IABP) insertion improves the surgical outcomes of coronary artery bypass grafting (CABG). Methods: Patients with EuroSCORE II > 1.2% who underwent CABG from 2009 to 2016 were included in the study. Patients who utilized intra-operative or post-operative IABP were excluded. The analysis included a total of 2907 patients, with 377 patients undergoing pre-operative IABP insertion and 1198 patients receiving no IABP support. Following propensity score matching, 250 patients from each group were eligible for further analysis. Results: 30-day mortality events occurred in 9 (3.6%) non-IABP users and in 12 (4.8%) IABP users (OR: 1.33 95%CI: 0.52–3.58). Kaplan-Meier survival curve analysis showed no significant differences between the two groups in mortality up to one year after the operation (p = 0.72). On multivariate analysis, IABP usage among the PSM patients was associated with lower 30-day mortality (OR: 0.28, 95%CI: 0.07–0.92, P-value = 0.043), 90-day mortality (OR: 0.26, 95%CI: 0.08–0.78, P-value = 0.022) and reduced risk of developing severe respiratory disorders (OR: 0.10, 95%CI:0.01–0.50, P-value = 0.011). Conclusion: Pre-operative IABP use in high-risk patients reduces 30- and 90-day mortality rates, along with a notable decrease in rates of severe respiratory disorders.

show abstract

Section: Discussionmentioning

confidence: 99%

Pre-operative intra-aortic balloon pump insertion in coronary artery bypass grafting patients reduces in-hospital morbidity

Sazzad,

Luo,

Chang

et al. 2024

Preprint

View full text Add to dashboard Cite

show abstract

“…These findings are consistent with those reported in numerous other studies within the field. Patients with such comorbidities are known to be at elevated risk for peripheral limb complications, including limb ischemia, IABP site infection, thrombosis, and the requirement for further interventions, often resulting in significant disability [ 24 , 25 ]. However, our study, after meticulous PSM, did not reveal a heightened incidence of such complications.…”

Section: Discussionmentioning

confidence: 99%

Is preoperative IABP insertion significantly reducing postoperative complication in augmented high-risk coronary artery bypass grafting patients?

Sazzad,

Luo,

Chang

et al. 2024

J Cardiothorac Surg

View full text Add to dashboard Cite

Background The aim of this study was to determine whether pre-operative intra-aortic balloon pump (IABP) insertion improves surgical outcomes in high-risk coronary artery bypass grafting (CABG) patients. Methods Patients with a EuroSCORE II greater than 1.2% who underwent CABG from 2009 to 2016 were included in the study, while those who utilized intra-operative or post-operative IABP were excluded. The analysis included a total of 2907 patients, with 377 patients undergoing preoperative IABP insertion (EuroSCORE II > 5.018%) and 1198 patients in the non-IABP group before matching; after propensity score matching (PSM), both groups consisted of a matched cohort of 250 patients. Results 30-day mortality events occurred in 9 (3.6%) non-IABP group and in 12 (4.8%) IABP patients (OR: 1.33 95%CI: 0.52–3.58). Kaplan-Meier survival curve analysis showed no significant differences between the two groups in mortality up to one year after the operation (p = 0.72). On multivariate analysis, IABP usage among the PSM patients was associated with lower 30-day mortality (OR: 0.28, 95%CI: 0.07–0.92, P-value = 0.043), 90-day mortality (OR: 0.26, 95%CI: 0.08–0.78, P-value = 0.022) and reduced risk of developing severe respiratory disorders (OR: 0.10, 95%CI:0.01–0.50, P-value = 0.011). Conclusion Pre-operative IABP use in high-risk patients reduces 30- and 90-day mortality rates, along with a notable decrease in rates of severe respiratory disorders.

show abstract

Use of intra‐aortic balloon pump during coronary artery bypass graft surgery. Current questions and few answers

Cited by 2 publications

References 22 publications

Pre-operative intra-aortic balloon pump insertion in coronary artery bypass grafting patients reduces in-hospital morbidity

Pre-operative intra-aortic balloon pump insertion in coronary artery bypass grafting patients reduces in-hospital morbidity

Is preoperative IABP insertion significantly reducing postoperative complication in augmented high-risk coronary artery bypass grafting patients?

Contact Info

Product

Resources

About